newsfilter
← Latest News
GlobeNewswire·

Neoleukin Therapeutics Announces Appointment of Donna Cochener as General Counsel

SEATTLE, March 15, 2022 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., "Neoleukin" (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced the appointment of